Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access Research article

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

Dirk Koczan, Susanne Drynda, Michael Hecker, Andreas Drynda, Reinhard Guthke, Joern Kekow and Hans-Juergen Thiesen*

Arthritis Research & Therapy 2008, 10:R50 doi:10.1186/ar2419

No comments have yet been made on this article.

Post a comment